The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
Abstract
Background and Aim: Although nonalcoholic fatty liver disease (NAFLD) is very common among morbidly obese patients, the effect of weight loss after bariatric surgery on inflammation and fibrosis related to NAFLD is still a matter of debate. The aim of this study was to evaluate the impact of Roux‐en‐Y gastric bypass (RYGB) surgery on NAFLD with a follow up of 2 years. Methods: Eighteen consecutive NAFLD patients with body mass index >40 kg/m 2 undergoing gastroplasty with RYGB were enrolled, and wedge liver biopsy was obtained at the operation. After 2 years, these patients underwent percutaneous liver biopsy. Results: At baseline, 67% of patients had nonalcoholic steatohepatitis (NASH) and 33% had steatosis, according to the NASH Clinical Research Network Scoring System (NAS) for biopsy. Cirrhosis was present in 5.5% of the patients with NASH. After a mean excess weight loss of 60%, steatosis disappeared in 84% and fibrosis disappeared in 75% of the patients. Hepatocellular ballooning disappeared in 50%. A slight lobular inflammatory infiltrate remained in 81%, apparently unrelated to fatty degeneration. As liver biochemical variables had been found within normal limits in 92.3% of patients at initial biopsy, no difference was found 2 years later. Lipid profile and blood sugar plasma concentration were closer to normal in all patients after 2 years (P < 0.05). Conclusions: Aspects of NAFLD including steatohepatitis improved significantly with massive weight loss at 2 years after RYGB surgery. No patient in this series had progression of hepatic fibrosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RYGB achieved steatosis remission in 89–95% of patients, especially in those with moderate-to-severe baseline steatosis (grades 2 and 3) [114,115,116,117].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [116]
In the citing paper
“RYGB also reduced MASH severity by 75–88.9%, with 38% of patients achieving full remission [114,116], while VSG achieved 100% resolution [118].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [116]
In the citing paper
“RYGB also reduced MASH severity by 75–88.9%, with 38% of patients achieving full remission [114,116], while VSG achieved 100% resolution [118].”
From Impact of Bariatric Surgery and Endoscopic Therapies on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Review (2025) · cites this paper as [116]
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Powell, E. E., Cooksley, G. W. E., Hanson, R., Searle, J., Halliday, J. W., & Powell, L. W. (1990) · Hepatology · doi:10.1002/hep.1840110114 · Cited by 1,473
Dixon, J. B., Bhathal, P. S., & O’Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,369
Tan, C. T., Ma, S., Wai, D. C. H., Chew, S. K., & Tai, E. S. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1182 · Cited by 824
Clinical Features and Natural History of Nonalcoholic Steatosis Syndromes
Falck-Ytter, Y. T., Younossi, Z. M., Marchesini, G., & McCullough, A. J. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-12926 · Cited by 668
Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., & Poehlman, E. T. (2002) · Circulation · doi:10.1161/hc0502.103331 · Cited by 541
Long term prognosis of fatty liver: risk of chronic liver disease and death
Dam‐Larsen, S., Franzmann, M., Andersen, I. B., Christoffersen, P., Jensen, L. B., Sørensen, T. I. A., Becker, U., & Bendtsen, F. (2004) · Gut · doi:10.1136/gut.2003.019984 · Cited by 511
MacDonald, K. G., Long, S. D., Swanson, M. S., Brown, B. M., Morris, P. G., Dohm, G. L., & Pories, W. J. (1997) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(97)80112-6 · Cited by 503
Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis
Kral, J. G., Thung, S. N., Biron, S., Hould, F.-S., Lebel, S., Marceau, S., Simard, S., & Marceau, P. (2004) · Surgery · doi:10.1016/j.surg.2003.10.003 · Cited by 322
Update on Nonalcoholic Fatty Liver Disease
McCullough, A. J. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200203000-00013 · Cited by 316
Recommendations for Reporting Weight Loss
Deitel, M., & Greenstein, R. J. (2003) · Obesity Surgery · doi:10.1381/096089203764467117 · Cited by 314
Luyckx, F., Lefebvre, P. J., & Scheen, A. J. (2000) · PubMed · Cited by 244
Torjesen, P. A., Birkeland, K. I., Anderssen, S. A., Hjermann, I., Holme, I., & Urdal, P. (1997) · Diabetes Care · doi:10.2337/diacare.20.1.26 · Cited by 196
Roux‐en‐Y Gastric Bypass Improves Liver Histology in Patients with Non‐Alcoholic Fatty Liver Disease
Clark, J. M., Al-Khuraishi, A., Solga, S. F., Alli, P. M., Diehl, A. M., & Magnuson, T. H. (2005) · Obesity Research · doi:10.1038/oby.2005.140 · Cited by 187
Liver Pathology in Morbidly Obese Patients Undergoing Roux-en-Y Gastric Bypass Surgery
Gholam, P. M., Kotler, D. P., & Flancbaum, L. (2002) · Obesity Surgery · doi:10.1381/096089202321144577 · Cited by 132
Non-alcoholic fatty liver disease: an emerging pathological spectrum
Zafrani, É. S. (2004) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0943-7 · Cited by 113
Steatohepatitis and fatal hepatic failure after biliopancreatic diversion.
Grimm, I. S., Schindler, W. R., & Haluszka, O. (1992) · PubMed · Cited by 110
Mottin, C. C., Moretto, M., Padoin, A. V., Kupski, C., Swarowsky, A. M., Glock, L., Duval, V., & da Silva, J. B. (2005) · Obesity Surgery · doi:10.1381/0960892054222830 · Cited by 97
Crespo, J., Fernández-Gil, P. L., Hernández‐Guerra, M., Cayón, A., Mayorga, M. M., Domínguez‐Díez, A., Fernández-Escalante, J. C., & Pons‐Romero, F. (2001) · Obesity Surgery · doi:10.1381/096089201321336548 · Cited by 84
Moretto, M., Kupski, C., Mottin, C. C., Repetto, G., Toneto, M. G., Rizzolli, J., Berleze, D., Brito, C. L. D. S., Casagrande, D. S., & de Paris, F. G. C. (2003) · Obesity Surgery · doi:10.1381/096089203322190853 · Cited by 82
Long-Term Consequences After Jejunoileal Bypass for Morbid Obesity
Hocking, M. P., Davis, G. L., Franzini, D. A., & Woodward, E. R. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026698602714 · Cited by 77
Prevalence of Non-alcoholic Steatohepatitis in Morbidly Obese Subjects Undergoing Gastric Bypass
Spaulding, L., Trainer, T. D., & Janiec, D. J. (2003) · Obesity Surgery · doi:10.1381/096089203765887633 · Cited by 69
de Oliveira, C. P. M. S., Faintuch, J., Rascovski, A., Junior, C. K. F., Bastos, M. D. S. C. B. D. O., Matsuda, M., Nina, B. I. D., Yahnosi, K., Abdalla, D. S. P., Paranaguá‐Vezozzo, D. C., et al. (2005) · Obesity Surgery · doi:10.1381/0960892053723493 · Cited by 47
Self-citationHopper, K. D., Grenko, R. T., TenHave, T. R., Hartzel, J. S., Sturtz, K. W., & Savage, C. A. (1995) · American Journal of Roentgenology · doi:10.2214/ajr.164.1.7998543 · Cited by 19
Cited by
Sorted by citations
ESPEN guideline on clinical nutrition in liver disease
Plauth, M., Bernal, W., Dasarathy, S., Merli, M., Plank, L. D., Schütz, T., & Bischoff, S. C. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.12.022 · Cited by 674
Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Vuppalanchi, R., & Chalasani, N. (2008) · Hepatology · doi:10.1002/hep.22603 · Cited by 568
Effect of bariatric surgery on nonalcoholic fatty liver disease: Systematic review and meta-analysis
Mummadi, R. R., Kasturi, K. S., Chennareddygari, S., & Sood, G. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.08.012 · Cited by 511
Mathurin, P., Hollebecque, A., Arnalsteen, L., Buob, D., Leteurtre, E., Caiazzo, R. J., Pigeyre, M., Verkindt, H., Dharancy, S., Louvet, A., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.052 · Cited by 490
Harrison, S. A., Fecht, W., Brunt, E. M., & Neuschwander‐Tetri, B. A. (2009) · Hepatology · doi:10.1002/hep.22575 · Cited by 470
Metadata
- Authors
- Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F., & Carrilho, F. J.
- Affiliations
- Universidade de São Paulo (BR)
- Corresponding author
- De Oliveira, Claudia P M S
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2007-03-20
- Volume
- 22
- Issue
- 4
- Pages
- 510-514
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W2067021370
- Cited by
- 193
- References
- 26
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 4 · 2023: 8 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 11 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 18 · 2014: 10 · 2013: 10 · 2012: 11
- FWCI
- 15.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Gastroenterology and Hepatology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Organ Transplantation Techniques and Outcomes
- Keywords
- non-alcoholic fatty liver disease, Roux-en-Y gastric bypass, bariatric surgery, morbid obesity, weight loss, nonalcoholic steatohepatitis, hepatic steatosis, liver fibrosis, liver biopsy, hepatocyte ballooning, liver cirrhosis, lipid profile, blood glucose
- MeSH terms
- Adult, Biopsy, Fatty Liver, Female, Follow-Up Studies, gamma-Glutamyltransferase, Humans, Lipids, Liver, Liver Cirrhosis, Male, Middle Aged, Obesity, Morbid, Comorbidity, Body Mass Index, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
